248 related articles for article (PubMed ID: 38017579)
1. Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs.
Deng H; Wei Z; Du J; Shen Z; Zhou C
Eur J Med Res; 2023 Nov; 28(1):548. PubMed ID: 38017579
[TBL] [Abstract][Full Text] [Related]
2. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
3. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
[TBL] [Abstract][Full Text] [Related]
4. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas.
Wei Z; Zhou C; Shen Y; Deng H; Shen Z
Medicine (Baltimore); 2023 Sep; 102(36):e34790. PubMed ID: 37682196
[TBL] [Abstract][Full Text] [Related]
6. Prognostic prediction of head and neck squamous cell carcinoma: Construction of cuproptosis-related long non-coding RNA signature.
Huang Q; You Q; Zhu N; Wu Z; Xiang Z; Wu K; Ren J; Gui Y
J Clin Lab Anal; 2022 Nov; 36(11):e24723. PubMed ID: 36189780
[TBL] [Abstract][Full Text] [Related]
7. Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma.
Xu Z; Zhang M; Guo Z; Chen L; Yang X; Li X; Liang Q; Tang Y; Liu J
Apoptosis; 2023 Jun; 28(5-6):860-880. PubMed ID: 36997733
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a prognostic signature based on seven endoplasmic reticulum stress-related lncRNAs for patients with head and neck squamous cell carcinoma.
Zhou M; Li H; Hu J; Zhou T; Zhou L; Li Y
Sci Rep; 2023 Dec; 13(1):22414. PubMed ID: 38104177
[TBL] [Abstract][Full Text] [Related]
9. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma.
Qiu L; Tao A; Sun X; Liu F; Ge X; Li C
Oncol Res; 2023; 31(5):715-752. PubMed ID: 37547764
[TBL] [Abstract][Full Text] [Related]
11. A novel cuproptosis-related lncRNA prognostic signature for predicting treatment and immune environment of head and neck squamous cell carcinoma.
Huan C; Gao J
Math Biosci Eng; 2022 Aug; 19(12):12127-12145. PubMed ID: 36653989
[TBL] [Abstract][Full Text] [Related]
12. 5-Methylcytosine-related lncRNAs: predicting prognosis and identifying hot and cold tumor subtypes in head and neck squamous cell carcinoma.
Huang J; Xu Z; Zhou C; Cheng L; Zeng H; Shen Y
World J Surg Oncol; 2023 Jun; 21(1):180. PubMed ID: 37312123
[TBL] [Abstract][Full Text] [Related]
13. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
[TBL] [Abstract][Full Text] [Related]
14. Necrotic related-lncRNAs: Prediction of prognosis and differentiation between cold and hot tumors in head and neck squamous cell carcinoma.
Shi Y; Zhang Y; Zuo N; Wang L; Sun X; Liang L; Ju M; Di X
Medicine (Baltimore); 2023 Jun; 102(23):e33994. PubMed ID: 37335630
[TBL] [Abstract][Full Text] [Related]
15. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
16. Constructing a Ferroptosis-related Long Non-coding RNA Signature to Predict the Prognostic of Head and Neck Squamous Cell Carcinoma Patients by Bioinformatic Analysis.
Lu R; Li Z; Yin S
Biochem Genet; 2022 Oct; 60(5):1825-1844. PubMed ID: 35098409
[TBL] [Abstract][Full Text] [Related]
17. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma.
He X; Xiao Y; Liu S; Deng R; Li Z; Zhu X
Biomed Res Int; 2022; 2022():3191474. PubMed ID: 36147630
[TBL] [Abstract][Full Text] [Related]
18. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma.
Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS
Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294
[TBL] [Abstract][Full Text] [Related]
20. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Shi Y; Huang J; Hu Y; Shen Y
BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
